Short-term control of glucokinase activity: Role of a regulatory protein, FASEB J, vol.8, pp.414-419, 1994. ,
Hormonal and Metabolite Regulation of Hepatic Glucokinase, Annu. Rev. Nutr, vol.36, pp.389-415, 2016. ,
Characterization of glucokinase-binding protein epitopes by a phage-displayed peptide library identification of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase as a novel interaction partner, J. Biol. Chem, vol.276, pp.43915-43923, 2001. ,
Hepatocytes contribute to residual glucose production in a mouse model for glycogen storage disease type Ia, Hepatology, vol.66, pp.2042-2054, 2017. ,
URL : https://hal.archives-ouvertes.fr/inserm-02339628
Glycogen storage disease type 1 and diabetes: Learning by comparing and contrasting the two disorders, Diabetes Metab, vol.39, pp.377-387, 2013. ,
Ameneiros-Rodríguez, E. Glycogen metabolism in humans, BBA Clin, vol.5, pp.85-100, 2016. ,
Regulation of hepatic glucose metabolism in health and disease, Nat. Rev. Endocrinol, vol.13, pp.572-587, 2017. ,
Liver glycogen turnover in fed and fasted humans, Am. J. Physiol, vol.266, pp.796-803, 1994. ,
De novo lipogenesis during controlled overfeeding with sucrose or glucose in lean and obese women, Am. J. Clin. Nutr, vol.74, pp.737-746, 2001. ,
Glycogen storage diseases: New perspectives, World J. Gastroenterol, vol.13, pp.2541-2553, 2007. ,
Interplay between ChREBP and SREBP-1c coordinates postprandial glycolysis and lipogenesis in livers of mice, J. Lipid Res, vol.59, pp.475-487, 2018. ,
A Whole-Body Model for Glycogen Regulation Reveals a Critical Role for Substrate Cycling in Maintaining Blood Glucose Homeostasis, PLoS Comput. Biol, 2011. ,
Control of Blood Glucose in the Absence of Hepatic Glucose Production During Prolonged Fasting in Mice, Diabetes, vol.60, pp.3121-3131, 2011. ,
New data and concepts on glutamine and glucose metabolism in the gut, Curr. Opin. Clin. Nutr. Metab. Care, vol.4, pp.267-271, 2001. ,
A novel role for glucose 6-phosphatase in the small intestine in the control of glucose homeostasis, J. Biol. Chem, vol.279, pp.44231-44234, 2004. ,
Gut-Brain Glucose Signaling in Energy Homeostasis, Cell Metab, vol.25, pp.1231-1242, 2017. ,
URL : https://hal.archives-ouvertes.fr/inserm-02339600
Protein feeding promotes redistribution of endogenous glucose production to the kidney and potentiates its suppression by insulin, Endocrinology, vol.150, pp.616-624, 2009. ,
Renal gluconeogenesis: Its importance in human glucose homeostasis, Diabetes Care, vol.24, pp.382-391, 2001. ,
Rat small intestine is an insulinsensitive gluconeogenic organ, Diabetes, vol.50, pp.740-746, 2001. ,
Contribution of intestine and kidney to glucose fluxes in different nutritional states in rat, Comp. Biochem. Physiol. B Biochem. Mol. Biol, vol.143, pp.195-200, 2006. ,
Targeted deletion of liver glucose-6 phosphatase mimics glycogen storage disease type 1a including development of multiple adenomas, J. Hepatol, vol.54, pp.529-537, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00575314
Intestinal gluconeogenesis is crucial to maintain a physiological fasting glycemia in the absence of hepatic glucose production in mice, Metab. Clin. Exp, vol.63, pp.104-111, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01859366
Behavior of transaldolase (EC 2.2.1.2) and transketolase (EC 2.2.1.1) Activities in normal, neoplastic, differentiating, and regenerating liver, Cancer Res, vol.36, pp.3189-3197, 1976. ,
Prevention of hepatocarcinogenesis and increased susceptibility to acetaminopheninduced liver failure in transaldolase-deficient mice by N-acetylcysteine, J. Clin. Investig, vol.119, pp.1546-1557, 2009. ,
Warburg's contributions to current concepts of cancer metabolism, Nat. Rev. Cancer, vol.11, pp.325-337, 2011. ,
, Links ChREBP and FXR to Glucose-Sensing. Front. Endocrinol, vol.5, p.230, 2015.
The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans, J. Clin. Investig, vol.122, pp.2176-2194, 2012. ,
Glucose 6-phosphate, rather than xylulose 5-phosphate, is required for the activation of ChREBP in response to glucose in the liver, J. Hepatol, vol.56, pp.199-209, 2012. ,
Deficiency of carbohydrate-activated transcription factor ChREBP prevents obesity and improves plasma glucose control in leptin-deficient (ob/ob) mice, Am. J. Physiol. Endocrinol. Metab, vol.291, pp.358-364, 2006. ,
ChREBP Rather Than SHP Regulates Hepatic VLDL Secretion, Nutrients, vol.10, p.321, 2018. ,
Genome-Wide Analysis of ChREBP Binding Sites on Male Mouse Liver and White Adipose Chromatin, Endocrinology, vol.156, pp.1982-1994, 2015. ,
Liverspecific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice, Diabetes, vol.55, pp.2159-2170, 2006. ,
Deletion of hepatic carbohydrate response element binding protein (ChREBP) impairs glucose homeostasis and hepatic insulin sensitivity in mice, Mol. Metab, vol.6, pp.1381-1394, 2017. ,
Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma, Gastroenterology, vol.140, pp.1071-1083, 2011. ,
Hepatocellular glycogenotic foci after combined intraportal pancreatic islet transplantation and knockout of the carbohydrate responsive element binding protein in diabetic mice, Oncotarget, vol.8, pp.104315-104329, 2017. ,
Oncogene-dependent addiction to carbohydrate-responsive element binding protein in hepatocellular carcinoma, Cell Cycle, vol.17, pp.1496-1512, 2018. ,
The glucose-responsive transcription factor ChREBP contributes to glucose-dependent anabolic synthesis and cell proliferation, Proc. Natl. Acad. Sci, vol.106, pp.21660-21665, 2009. ,
A link between hepatic glucose production and peripheral energy metabolism via hepatokines, Mol. Metab, vol.3, pp.531-543, 2014. ,
URL : https://hal.archives-ouvertes.fr/inserm-01350728
Dietary exacerbation of metabolic stress leads to accelerated hepatic carcinogenesis in glycogen storage disease type Ia, J. Hepatol, vol.69, pp.1074-1087, 2018. ,
URL : https://hal.archives-ouvertes.fr/inserm-02339527
De novo lipogenesis in human fat and liver is linked to ChREBP? and metabolic health, Nat. Commun, 1528. ,
Novel insights into ChREBP regulation and function, Trends Endocrinol. Metab, vol.24, pp.257-268, 2013. ,
Xylulose 5-phosphate mediates glucose-induced lipogenesis by xylulose 5-phosphate-activated protein phosphatase in rat liver, Proc. Natl. Acad. Sci, vol.100, pp.5107-5112, 2003. ,
A novel N-terminal domain may dictate the glucose response of Mondo proteins, PLoS ONE, vol.7, p.34803, 2012. ,
Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice, J. Clin. Investig, vol.120, pp.4316-4331, 2010. ,
O-GlcNAcylation Increases ChREBP Protein Content and Transcriptional Activity in the Liver, Diabetes, vol.60, pp.1399-1413, 2011. ,
Glucose activates ChREBP by increasing its rate of nuclear entry and relieving repression of its transcriptional activity, J. Biol. Chem, vol.283, pp.24029-24038, 2008. ,
Metabolite Regulation of Nuclear Localization of Carbohydrate-response Elementbinding Protein (ChREBP): ROLE OF AMP AS AN ALLOSTERIC INHIBITOR, J. Biol. Chem, vol.291, pp.10515-10527, 2016. ,
, Carbohydrate Sensing Through the Transcription Factor ChREBP. Front. Genet, vol.10, p.472, 2019.
ChREBP regulates fructose-induced glucose production independently of insulin signaling, J. Clin. Investig, vol.126, pp.4372-4386, 2016. ,
Type 2 Diabetes: Demystifying the Global Epidemic, vol.66, pp.1432-1442, 2017. ,
The worldwide epidemiology of type 2 diabetes mellitus--present and future perspectives, Nat. Rev. Endocrinol, vol.8, pp.228-236, 2012. ,
Hormonal regulation of hepatic glucose production in health and disease, Cell Metab, vol.14, pp.9-19, 2011. ,
Biochemistry and molecular cell biology of diabetic complications, Nature, vol.414, pp.813-820, 2001. ,
Diagnosis and management of glycogen storage disease type I: A practice guideline of the American College of Medical Genetics and Genomics, Genet. Med, p.1, 2014. ,
Non-alcoholic fatty liver disease, Crit. Rev. Clin. Lab. Sci, vol.48, pp.97-113, 2011. ,
Non-alcoholic fatty liver disease and diabetes, Metab. Clin. Exp, vol.65, pp.1096-1108, 2016. ,
Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: The Edinburgh Type 2 Diabetes Study, Diabetes Care, vol.34, pp.1139-1144, 2011. ,
Insulin-dependent and -independent regulation of sterol regulatory elementbinding protein-1c, J. Diabetes Investig, vol.4, pp.411-412, 2013. ,
Carbohydrate-response-element-binding protein (ChREBP) and not the liver X receptor ? (LXR?) mediates elevated hepatic lipogenic gene expression in a mouse model of glycogen storage disease type 1, Biochem. J, vol.432, pp.249-254, 2010. ,
Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: Lessons from genetically engineered mice, J. Clin. Investig, vol.118, pp.829-838, 2008. ,
Increased de novo Lipogenesis and Delayed Conversion of Large VLDL into Intermediate Density Lipoprotein Particles Contribute to Hyperlipidemia in Glycogen Storage Disease Type 1a, Pediatr. Res, vol.63, pp.702-707, 2008. ,
Mechanisms by Which Metabolic Reprogramming in GSD1 Liver Generates a Favorable Tumorigenic Environment, J. Inborn Errors Metab. Screen, vol.4, 2016. ,
The Natural Course of Non-Alcoholic Fatty Liver Disease, Int. J. Mol. Sci, vol.17, p.774, 2016. ,
Population-based risk factors and resource utilization for HCC: US perspective, Curr. Med. Res. Opin, vol.26, pp.2183-2191, 2010. ,
Characteristics and outcome of hepatocellular carcinoma in patients with NAFLD without cirrhosis, Liver Int, vol.39, pp.1098-1108, 2019. ,
Intracellular lipids are an independent cause of liver injury and chronic kidney disease in non alcoholic fatty liver disease-like context, Mol. Metab, vol.16, pp.100-115, 2018. ,
URL : https://hal.archives-ouvertes.fr/inserm-02339561
Non-alcoholic steatohepatitis: Emerging molecular targets and therapeutic strategies, Nat. Rev. Drug Discov, vol.15, pp.249-274, 2016. ,
Bezafibrate induces autophagy and improves hepatic lipid metabolism in glycogen storage disease type Ia, Hum. Mol. Genet, vol.28, pp.143-154, 2018. ,
Chemical Hybridization of Glucagon and Thyroid Hormone Optimizes Therapeutic Impact for Metabolic Disease, Cell, vol.167, pp.843-857, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01607311
Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats, Science, vol.347, pp.1253-1256, 2015. ,
Reversal of hypertriglyceridemia, fatty liver disease, and insulin resistance by a livertargeted mitochondrial uncoupler, Cell Metab, vol.18, pp.740-748, 2013. ,